scholarly journals A review on role of Pratimarsha Nasya with Anutaila in the prevention of covid-19

2021 ◽  
Vol 5 (02) ◽  
Author(s):  
Ashwini R. Parkanthe ◽  
Brijesh Mishra
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Respiratory Disease ◽  
Respiratory Infections ◽  
Promising Result ◽  
Preventive Measure ◽  
Sars Coronavirus ◽  
The Family ◽  
The World ◽  
Novel Coronavirus

The severe acute respiratory syndrome (SARS) coronavirus-2 is a novel coronavirus belonging to the family coronaviridae and is now known to be responsible for the outbreak of a series of recent acute atypical respiratory infections originating in Wuhan, China. The disease caused by this virus, termed coronavirus disease 19 or simply Covid-19, has rapidly spread throughout the world at an alarming pace and has been declared a pandemic by the WHO on March 11, 2020. In Ayurveda pandemic is explained in Charak Samhita viman sthana under Janpadodhwansiya adhyaya. Till date no medicine or therapy has demonstrated promising result in Covid-19. So, we can prevent and defend this disease by boosting own immunity. Which can be achieved by adopting ayurvedic measures such as following proper Dincharya, Ritucharya, Sadvritta, Achar Rasayan Panchkarma etc. These practices lay emphasis on prevention of disease and promotion of health, one of such preventive measure is Pratimarsha nasya. Pratimarsha Nasya with Anutaila explained in Dincharya. Most of ingredients of Anutaila possess Anti-inflammatory, Anti-pyretic, Anti-viral properties ultimately these functions of Anutaila will lead to enhancement of respiratory immunity and will help in prevention of covid-19 a respiratory disease.

AN INTERESTING STUDY OF RHINO-ORBITAL MUCORMYCOSIS IN COVID-19 PATIENTS

2021 ◽  
pp. 28-29
Author(s):  
Kokila G. Kamath ◽  
Vishal S Jadhav
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Respiratory Infections ◽  
Age Groups ◽  
Fungal Disease ◽  
Sars Coronavirus ◽  
Interesting Study ◽  
Wide Range ◽  
The Family ◽  
Novel Coronavirus

The Severe Acute Respiratory Syndrome (SARS) coronavirus-2 is a novel coronavirus, belonging to the family coronaviridae and is now known to be responsible for the outbreak of a series of recent acute atypical respiratory infections originating in Wuhan, China, termed as coronavirus disease 19 (COVID-19) and has been declared a pandemic by WHO on March 11, 2020. COVID-19 infections may be associated with a wide range of bacterial and fungal co-infections. We report the study of 4 cases, who in our hospital, developed Rhino-orbital mucormycosis, who were diagnosed as COVID-19 positive, with or without associated co-morbidities, involving all age groups. Extensive use of steroids may lead to development or exacerbation of a pre-existing fungal disease in patients with COVID-19 infections.

scholarly journals COVID 19-An Update on Oral Changes

2021 ◽  
pp. 74-79
Author(s):  
Srividhya Srinivasan ◽  
K. Saraswathi Gopal ◽  
P. Mahesh Kumar ◽  
V. Poongodi ◽  
R. Anitha
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Clinical Presentation ◽  
Oral Manifestations ◽  
Sars Coronavirus ◽  
The Family ◽  
Novel Coronavirus

The Severe Acute Respiratory Syndrome (SARS) coronavirus-2 is a novel coronavirus belonging to the family Coronaviridae originating in Wuhan, China has created a  impact across the globe. The disease has been declared a pandemic by the WHO on March 11, 2020. In this review, an update on virology, pathophysiology, clinical presentation with detailed update on oral manifestations .

scholarly journals Role for Nonstructural Protein 1 of Severe Acute Respiratory Syndrome Coronavirus in Chemokine Dysregulation

2006 ◽  
Vol 81 (1) ◽  
pp. 416-422 ◽  
Author(s):  
Anna H. Y. Law ◽  
Davy C. W. Lee ◽  
Benny K. W. Cheung ◽  
Howard C. H. Yim ◽  
Allan S. Y. Lau
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Nonstructural Protein ◽  
Lung Epithelial Cells ◽  
Sars Coronavirus ◽  
Cytokine Induction ◽  
Nonstructural Protein 1 ◽  
Lung Epithelial ◽  
Novel Coronavirus ◽  
Factor Interactions

ABSTRACT Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus. Since its associated morbidity and mortality have been postulated to be due to immune dysregulation, we investigated which of the viral proteins is responsible for chemokine overexpression. To delineate the viral and cellular factor interactions, the role of four SARS coronavirus proteins, including nonstructural protein 1 (nsp-1), nsp-5, envelope, and membrane, were examined in terms of cytokine induction. Our results showed that the SARS coronavirus nsp-1 plays an important role in CCL5, CXCL10, and CCL3 expression in human lung epithelial cells via the activation of NF-κB.

scholarly journals The SARS-CoV-2 Pandemic and the Role of Honey and its Products as an Emerging Therapeutic Regime: A Review

BioMedica ◽  
2020 ◽  
Vol 36 (2S) ◽  
pp. 201-205
Author(s):  
Fatima Tuz Zahra ◽  
Sidrah Saleem ◽  
Muhammad Imran ◽  
Ayesha Ghazal ◽  
Usman Arshad
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Infected Individual ◽  
Antiviral Effect ◽  
Biological Features ◽  
Antiviral Effects ◽  
Therapeutic Regime ◽  
The World ◽  
Initial Source ◽  
Novel Coronavirus

<p>The outbreak of pneumonia that broke out in Wuhan, in December 2019, later rapidly spread to the rest of the world. This was identified as Coronavirus disease 2019 (COVID-19) [officially renamed severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)] caused by a zoonotic beta Coronavirus entitled 2019 novel Coronavirus (2019-nCoV). The aim of this study was to summarize the biological features of SARSCoV-2, its clinical features and the possible antiviral effect of honey against SARS-CoV-2. For this purpose, recently published literature, official documents and selected up-to-date preprint studies were reviewed. The initial source of SARS-CoV-2 is still unknown but a possible animal-to-human transmission is indicated. Human spread of SARS-CoV-2 is due to droplet spread. The infected individual may present as symptomatic or asymptomatic, this varies from patient to patient mainly depending upon his/her immunity. To combat the current pandemic various modalities are under study, an important and harmless way of treatment might be the use of honey. Various studies have demonstrated antiviral effects of honey. Propolis and honey have shown promising anti-viral effect against SARS-CoV-2. Thus, the combined effect of honey and its products might open a door for developing a safe and highly efficient natural drug against COVID-19<br />infection.</p>

scholarly journals COVID-19 pandemic: The deadly respiratory disease of 21st century

2021 ◽  
Vol 11 (1) ◽  
pp. 01-18
Author(s):  
Shweta Jain ◽  
◽  
Pankaj Kumar Jain ◽  
Ramakant Yadav ◽  
Surendra Kumar Jain ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Respiratory Disease ◽  
Clinical Investigation ◽  
Respiratory Illness ◽  
The Novel ◽  
Major Threat ◽  
The World ◽  
Prevention And Treatment ◽  
Novel Coronavirus ◽  
Severe Respiratory Illness

The sudden outbreak of 2019 novel coronavirus (2019-nCoV) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated from Wuhan, China. SARS-CoV-2 causes severe respiratory illness and becomes a major threat for humanity. Recently the entire scientist, researchers and physicians all over the countries focused to find the treatment of this pandemic disease. Numerous drugs and or vaccines have been trialed for prevention and treatment against 2019-nCoV but no therapy has been shown effective to date. Currently, numerous vaccines are under clinical investigation and mRNA-1273 vaccine (LNP- encapsulated mRNA vaccine encoding S protein) from Moderna is ahead. Although chloroquine, hydroxychloroquine, remdesivir and many other drugs had recommended against SARS-CoV-2, but still they are not the guarantee treatment of COVID-19. Recently, India, America, Russia and China introduced vaccines against COVID-19 in the market, however assurance of their 100% effectiveness are doubtful. The speed of daily new cases threatens the world and urges the scientist to crack this pandemic condition. KEYWORDS: 2019-nCoV; Chloroquine; COVID-19; Moderna; Respiratory disease; Remdesivir.

Role of Lachesis and Gripp Heel in the Treatment of COVID-19

2020 ◽  
Vol 33 (03) ◽  
pp. 233-234
Author(s):  
Md Aminul Islam
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Respiratory System ◽  
The World ◽  
Effective Role ◽  
Novel Coronavirus ◽  
Human Death

AbstractFrom December 2019, a new pandemic named Coronavirus Disease 2019 (COVID-2019) has become a key topic of discussion across the world. The reason behind this discussion is the rapid increase in human death due to COVID-19 which has stunned the world. The pathogen of COVID-19 is a novel coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which is similar to SARS CoV. SARS-CoV-2 infects mainly the respiratory system which causes the death because there is no effective vaccines or therapeutics against COVID-19. Homoeopathic drugs like Lachesis and Gripp Heel may play an effective role to cure corona patients.

Plasma therapy a possible hope to fight against COVID-19

2020 ◽  
Author(s):  
Ravikant Piyush ◽  
Aroni Chatterjee ◽  
Shashikant Ray
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Viral Disease ◽  
Plasma Therapy ◽  
Therapeutic Drugs ◽  
Wild Fire ◽  
The World ◽  
Short Span ◽  
Game Changer

The world is currently going through a disastrous event and a catastrophic upheaval caused by the coronavirus disease 2019 (COVID-19). The pandemic has resulted in loss of more than 150000 deaths across the globe. Originating from China and spreading across all continents within a short span of time, it has become a matter of international emergency. Different agencies are adopting diverse approaches to stop and spread of this viral disease but still now nothing confirmatory has come up. Due to lack of vaccines and proper therapeutic drugs, the disease is still spreading like wild fire without control. An Old but very promising method- the convalescent plasma therapy could be the key therapy to stop this pandemic. This method has already proven its mettle on several occasions previously and has been found to be effective in curing the pandemics induced by Ebola, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the same group of β-Coronavirus that has resulted in the above diseases. Therefore, the role of plasma therapy is being explored for treatment of this disease. In this review, we have mainly focused on the role of convalescent plasma therapy and why its use should be promoted in fight against COVID-19, as it could turn out to be a game changer.

Treatment Options in COVID-19: The Role of Bioavailable Antiviral Ribonucleoside Analog on NHC in vitro

2020 ◽  
Author(s):  
Lara Bittmann
Keyword(s):  
World Health Organization ◽  
Clinical Picture ◽  
Treatment Options ◽  
World Health ◽  
Wuhan City ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

On December 31, 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on January 7, 2020 and was provisionally named "2019-nCoV". This new Coronavirus causes a clinical picture which has received now the name COVID-19. The virus has spread subsequently worldwide and was explained on the 11th of March, 2020 by the World Health Organization to the pandemic.

Therapeutic role of vegetables in Respiratory Diseases – A critical review from Ayurvedic classics.

2016 ◽  
Vol 1 (3) ◽  
Author(s):  
Dr. Raghavendra Naik ◽  
Shweta Vekariya ◽  
R. N. Acharya ◽  
Sneha D. Borkar
Keyword(s):  
Clinical Practice ◽  
Respiratory Disease ◽  
Respiratory System ◽  
Critical Review ◽  
Critical Analysis ◽  
Respiratory Diseases ◽  
Unique Contribution ◽  
Pharmacological Activities ◽  
The Family

The concept of Pathya (wholesome diet) is an unique contribution of Ayurveda, which plays an important role in prevention and management of many diseases. “Shakavarga”, a category under dietetics in classical texts of Ayurveda enlisted different vegetables with their properties and indications in different disease conditions. These vegetables can be prescribed as Pathya (wholesome diet) in clinical practice. In the present review, plants described under Shakavarga, indicated as Pathya in different diseases related to Pranavaha Srotas (Respiratory system) were compiled from 15 different Ayurvedic classical texts. Critical analysis of the compiled data reveals that out of 332 vegetables described under Shakavarga, 44 are indicated in respiratory disease like Shvasa (Dyspnoea/Asthma), Kasa (Cough), Peenasa (Chronic rhinitis) and Hikka (Hiccup). Among them, botanical identity of 42 classical plants has been established and maximum number of vegetables belongs to the family cucurbitaceae (10) followed by solanaceae (4). Some of these vegetables have been reported for their various pharmacological activities related to prevention and management of diseases related to Pranavaha Srotas (Respiratory system). These vegetables are reported for their anti-inflammatory (16), antioxidant (14), anti-allergic (6) and antitussive (3) activities. The observed result may be helpful in use of vegetables as Pathya (wholesome diet) and planning further scientific studies about the efficacy of these plants on prevention as well as management of respiratory diseases.

scholarly journals Mesenchymal Stem Cells: The Secret Children’s Weapons against the SARS-CoV-2 Lethal Infection

2021 ◽  
Vol 11 (4) ◽  
pp. 1696
Author(s):  
Mario Giosuè Balzanelli ◽  
Pietro Distratis ◽  
Orazio Catucci ◽  
Angelo Cefalo ◽  
Rita Lazzaro ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Respiratory Infections ◽  
Acute Respiratory Infections ◽  
Unusual Event ◽  
Inflammatory Processes ◽  
Life Threatening ◽  
Severe Acute Respiratory Infections ◽  
Novel Coronavirus

Due to the promising effects of mesenchymal stem cells (MSCs) in the treatment of various diseases, this commentary aimed to focus on the auxiliary role of MSCs to reduce inflammatory processes of acute respiratory infections caused by the 2019 novel coronavirus (COVID-19). Since early in 2020, COVID-19, a consequence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly affected millions of people world-wide. The SARS-CoV-2 infection in children appears to be an unusual event. Despite the high number of affected adult and elderly, children and adolescents remained low in amounts, and marginally touched. Based on the promising role of cell therapy and regenerative medicine approaches in the treatment of several life-threatening diseases, it seems that applying MSCs cell-based approaches can also be a hopeful strategy for improving subjects with severe acute respiratory infections caused by COVID-19.

Sign in / Sign up

Export Citation Format

Share Document